Myeloma Biology and Therapeutics Group
Dr Charlotte Pawlyn's group focusses on identifying and validating therapeutic targets for the treatment of immunomodulatory drug resistant and high-risk multiple myeloma, a bone marrow cancer.
Dr Charlotte Pawlyn
Group Leader:
Myeloma Biology and Therapeutics
Dr Charlotte Pawlyn is the group leader of the Myeloma Biology and Therapeutics Group and Career Development Faculty at the Institute of Cancer Research and an Honorary Consultant in Haematology at The Royal Marsden NHS Foundation Trust.
Researchers in this group
.
Dr Charlotte Pawlyn's group have written 79 publications
Most recent new publication 8/2024
See all their publications